# Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study

> **NCT00497666** · — · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center**

## Conditions studied

- Diabetes
- Diabetic Nephropathy
- Renal Protection

## Interventions

- **DRUG:** Rosiglitasone (retrospective observation)

## Key facts

- **NCT ID:** NCT00497666
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** — (—)
- **Last updated:** 2007-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497666, "Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00497666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*